Esperanza Martín-Sánchez

9PUBLICATIONS
93CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Jul 10, 2024
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.

Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero

|Sep 08, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.

Rosalinda Termini, David Žihala, Evangelos Terpos

|Dec 15, 2021
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.

Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia

|Oct 23, 2021
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis.

Saioa Mendaza, David Guerrero-Setas, Iñaki Monreal-Santesteban

Pageof 2